CM
Crestline Management Portfolio holdings
AUM
$62.6M
This Quarter Return
+25.63%
1 Year Return
-18.06%
3 Year Return
+16.7%
5 Year Return
+67.08%
10 Year Return
+99.86%
AUM
$745M
AUM Growth
+$745M
(+36%)
Cap. Flow
+$66.7M
Cap. Flow
% of AUM
8.96%
Top 10 Holdings %
Top 10 Hldgs %
76.65%
Holding
188
New
74
Increased
30
Reduced
20
Closed
60
Top Buys
| 1 |
MON
Monsanto Co
MON
|
$6.27M |
| 2 |
Verisk Analytics
VRSK
|
$5.84M |
| 3 |
Air Products & Chemicals
APD
|
$4.65M |
| 4 |
DNB
Dun & Bradstreet
DNB
|
$4.61M |
| 5 |
Honeywell
HON
|
$4.13M |
Top Sells
| 1 |
FNB Corp
FNB
|
$5.24M |
| 2 |
Dover
DOV
|
$4.9M |
| 3 |
Associated Banc-Corp
ASB
|
$3.9M |
| 4 |
KeyCorp
KEY
|
$3.73M |
| 5 |
PACW
PacWest Bancorp
PACW
|
$2.8M |
Sector Composition
| 1 | Financials | 12.57% |
| 2 | Healthcare | 6.09% |
| 3 | Industrials | 5.44% |
| 4 | Materials | 3.11% |
| 5 | Technology | 1.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Visa
V
$681B
| $2.65M | 0.36% |
+28,254
| New | +$2.65M |
|
27
Biogen
BIIB
$20.8B
| $2.59M | 0.35% |
+9,543
| New | +$2.59M |
|
|
AGU
28
DELISTED
Agrium
AGU
| $2.58M | 0.35% |
28,500
-21,500
| -43% | -$1.95M |
|
29
Assurant
AIZ
$10.8B
| $2.53M | 0.34% |
+24,376
| New | +$2.53M |
|
30
United Bankshares
UBSI
$5.39B
| $2.43M | 0.33% |
+62,000
| New | +$2.43M |
|
31
MetLife
MET
$53.6B
| $2.39M | 0.32% |
+43,555
| New | +$2.39M |
|
32
Fair Isaac
FICO
$36.5B
| $2.31M | 0.31% |
+16,545
| New | +$2.31M |
|
|
AMTD
33
DELISTED
TD Ameritrade Holding Corp
AMTD
| $2.3M | 0.31% |
+53,407
| New | +$2.3M |
|
34
Fifth Third Bancorp
FITB
$30.2B
| $2.21M | 0.3% |
+85,000
| New | +$2.21M |
|
35
Citizens Financial Group
CFG
$22.3B
| $2.14M | 0.29% |
+60,000
| New | +$2.14M |
|
36
US Bancorp
USB
$75.5B
| $2.08M | 0.28% |
40,000
-30,000
| -43% | -$1.56M |
|
37
Sarepta Therapeutics
SRPT
$1.98B
| $2.07M | 0.28% |
61,410
+28,810
| +88% | +$971K |
|
38
JetBlue
JBLU
$1.98B
| $2.06M | 0.28% |
90,000
-50,000
| -36% | -$1.14M |
|
39
Neurocrine Biosciences
NBIX
$13.5B
| $2.05M | 0.28% |
+44,658
| New | +$2.05M |
|
40
BioMarin Pharmaceuticals
BMRN
$11.3B
| $2.05M | 0.27% |
22,592
-2,207
| -9% | -$200K |
|
41
Cathay General Bancorp
CATY
$3.44B
| $2.05M | 0.27% |
54,000
+34,000
| +170% | +$1.29M |
|
|
ATH
42
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $2.02M | 0.27% |
+40,698
| New | +$2.02M |
|
43
Bank of Hawaii
BOH
$2.69B
| $1.99M | 0.27% |
24,000
| – | – |
|
44
Trex
TREX
$6.41B
| $1.92M | 0.26% |
28,351
+11,951
| +73% | +$809K |
|
45
Esperion Therapeutics
ESPR
$490M
| $1.9M | 0.25% |
40,966
+13,566
| +50% | +$628K |
|
|
TSS
46
DELISTED
Total System Services, Inc.
TSS
| $1.86M | 0.25% |
+31,930
| New | +$1.86M |
|
47
PTC Therapeutics
PTCT
$4.41B
| $1.79M | 0.24% |
+97,789
| New | +$1.79M |
|
48
Enovis
ENOV
$1.75B
| $1.77M | 0.24% |
44,931
-423
| -0.9% | -$16.7K |
|
49
Humana
HUM
$37.5B
| $1.74M | 0.23% |
+7,212
| New | +$1.74M |
|
|
PRTK
50
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $1.73M | 0.23% |
+71,799
| New | +$1.73M |
|